Personalized Medicines Will Help Vendors Gain a Competitive Edge in the Global Lung Cancer Therapeutics Market by 2019: TechNavio
London, 24 November 2014 – The high unmet need for personalized drugs has propelled growth in the Global Lung Cancer Therapeutics Market, which is expected to post a CAGR of 3.80 percent from 2015-2019, says research firm TechNavio. There is currently no cure for lung cancer. Hence, drugs that cause disease remission in patients…
